Charles Sharpe, MD
Internal Medicine · Athens, TNNPI 1578568648
Payments from drug & device makers
Across 725 payments — averaging $134.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk AS$67K
- Novartis$25K
- Novo Nordisk$2K
- Amgen$867
- Pfizer$590
- AbbVie$395
- plus $2K from 24 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk AS | 302 | $67,258 |
| Novartis | 21 | $24,945 |
| Novo Nordisk | 122 | $1,545 |
| Amgen | 78 | $867 |
| Pfizer | 37 | $590 |
| AbbVie | 26 | $395 |
| Lilly USA, LLC | 21 | $318 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 12 | $231 |
| Bayer | 12 | $197 |
| E.r. Squibb & Sons, L.L.C. | 13 | $167 |
| Johnson & Johnson | 11 | $164 |
| AstraZeneca | 11 | $145 |
| GSK | 7 | $129 |
| Boehringer Ingelheim | 8 | $120 |
| Merck | 8 | $110 |
| Xeris Pharmaceuticals, Inc. | 5 | $108 |
| Sanofi-aventis U.S. LLC | 5 | $87 |
| Esperion Therapeutics, Inc. | 4 | $71 |
| Abbott | 4 | $71 |
| Dynavax Technologies Corporation | 3 | $70 |
| Axsome Therapeutics, Inc. | 3 | $57 |
| Amarin Pharma, Inc. | 2 | $48 |
| Jazz Pharmaceuticals Inc. | 2 | $46 |
| Astellas Pharma US Inc | 1 | $31 |
| Currax Pharmaceuticals LLC | 2 | $27 |
| Philips North America LLC | 1 | $22 |
| Heartflow, Inc. | 1 | $16 |
| Exact Sciences | 1 | $16 |
| Medtronic | 1 | $12 |
| Phathom Pharmaceuticals, Inc. | 1 | $9 |
How this compares
$97,871 in reported general payments places this provider in the 95th percentile of 2,216 internal medicine providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Athens
- Mark McKenzieChattanooga$11.9M
- Bernard GrunstraBristol$6.4M
- Jewel WhiteKingsport$5.7M
- Judith WhiteKingsport$5.6M
- Obadias MarquezOoltewah$2.8M
- Amanda Moore MillerKnoxville$2.3M
- Rick WhilesBristol$1.5M
- John AndersonNashville$1.5M
- David MorinKingsport$1.4M
- John KirbyJefferson City$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.